Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. (Q53864608)

21 May 2018

title

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. (English)

1 reference

21 May 2018

0 references

1 reference

Schroers R

1

1 reference

21 May 2018

Griesinger F

2

1 reference

21 May 2018

Trümper L

3

1 reference

21 May 2018

Haase D

4

1 reference

21 May 2018

Kulle B

5

1 reference

21 May 2018

Klein-Hitpass L

6

1 reference

21 May 2018

Sellmann L

7

1 reference

21 May 2018

Dührsen U

8

1 reference

21 May 2018

Dürig J

9

1 reference

21 May 2018

publication date

1 May 2005

1 reference

21 May 2018

published in

Leukemia

1 reference

21 May 2018

volume

19

1 reference

21 May 2018

issue

5

1 reference

21 May 2018

page(s)

750-758

1 reference

21 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403707

exact match

0 references

cites work

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

CD38 modifications in chronic lymphocytic leukemia: are they relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

When and how to treat chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

inferred from DOI database lookup

7 January 2021

based on heuristic

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

inferred from DOI database lookup

7 January 2021

based on heuristic

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403707

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403707

1 reference

21 May 2018

PubMed ID

15759031

1 reference

21 May 2018